CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer

By sjmartinez • March 30, 2025

Huynh JT, Li R, Shin DS. CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer. J Natl Compr Canc Netw. 2025 Mar 28;23(3.5):CRE25-050. doi: 10.6004/jnccn.2024.7225. PMID: 40154310.

Tags: Fellow, General Internal Medicine, Hematology/Oncology, Publications, Resident

Symptom Burden After Dialysis Initiation and Its Association With Hospitalization

Nair D, Cai X, Hays RD, Aiyegbusi OL, Frazier RS, Isakova T, Peipert JD. Symptom Burden After Dialysis Initiation and Its Association With Hospitalization. Kidney[...]

Unmasking Factor XIII Deficiency: Recurrent Intracranial Hemorrhage Despite Normal Coagulation Studies

Ramesh K, Hui G, Shodiya M, Palaskas NJ. Unmasking Factor XIII Deficiency: Recurrent Intracranial Hemorrhage Despite Normal Coagulation Studies. Cureus. 2026 Jul 29;18(7):e113621. doi: 10.7759/cureus.113621.[...]

Urgent Chemotherapy for Aggressive Metastatic Neuroendocrine Cancer With Impending Hepatic Failure: A Case Report

Rashba GB, Kaplan L, Bolos D, Baltayan A, Backer S. Urgent Chemotherapy for Aggressive Metastatic Neuroendocrine Cancer With Impending Hepatic Failure: A Case Report. Cureus.[...]